Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry

NCT06903234 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemoglobinuria, Paroxysmal

Interventions

DRUG: Iptacopan

Sponsor

Novartis Pharmaceuticals